Trials / Completed
CompletedNCT03183089
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
A Randomized, Single-Center, Comparative Study of Rohto Dry-Aid® and Systane® Ultra in the Management of Tear Film Stability and Visual Function in Patients With Dry Eye
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- The Mentholatum Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy of Rohto Dry-Aid® in comparison to Systane® Ultra on visual function and tear film stability in patients diagnosed with Dry Eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rohto Dry-Aid® | |
| DRUG | Systane® Ultra |
Timeline
- Start date
- 2015-12-03
- Primary completion
- 2016-01-04
- Completion
- 2016-01-04
- First posted
- 2017-06-09
- Last updated
- 2017-06-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03183089. Inclusion in this directory is not an endorsement.